Literature DB >> 1354297

Treatment of hypercholesterolaemia in children.

H Sinzinger, P Schmid, C Pirich, I Virgolini, B Pesau, S Granegger, J O'Grady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1354297     DOI： 10.1016/0140-6736(92)91745-t

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Lipid lowering in the young.

Authors:  G R Thompson
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 3.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

4.  Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood.

Authors:  J E Coleman; A R Watson
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 5.  Statins in children: what do we know and what do we need to do?

Authors:  D M Black
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

Review 6.  Choices for treatment of hyperlipidaemia.

Authors:  S Tonstad
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 7.  Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.

Authors:  L Iughetti; B Predieri; F Balli; S Calandra
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 8.  Type 2 diabetes mellitus in adolescence: lipid and cardiovascular risk factors.

Authors:  Kenneth Lee Jones; Asheesh Kumar Dewan
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.